Publication: Potential of RNAi applications to control viral diseases of farmed shrimp
2
Issued Date
2017-07-01
Resource Type
ISSN
10960805
00222011
00222011
Other identifier(s)
2-s2.0-85008144250
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Invertebrate Pathology. Vol.147, (2017), 76-85
Suggested Citation
Ornchuma Itsathitphaisarn, Siripong Thitamadee, Wattana Weerachatyanukul, Kallaya Sritunyalucksana Potential of RNAi applications to control viral diseases of farmed shrimp. Journal of Invertebrate Pathology. Vol.147, (2017), 76-85. doi:10.1016/j.jip.2016.11.006 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/41417
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Potential of RNAi applications to control viral diseases of farmed shrimp
Other Contributor(s)
Abstract
© 2016 Elsevier Inc. Viral pathogens pose a primary threat to global shrimp aquaculture. Despite the urgent industry need for them, practical anti-viral control methods are unavailable due, in part, to lack of an adaptive immune response in crustaceans that renders conventional vaccination methods ineffective. One currently studied method of high interest for protecting shrimp against viral infection relies on the post-transcriptional gene silencing mechanism called RNA interference (RNAi) that is induced by gene-specific constructs of double stranded RNA (dsRNA). Although this approach was first described for successful protection of shrimp against white spot disease (WSD) by injecting dsRNA specific to genes of white spot syndrome virus (WSSV) into shrimp in the laboratory in 2005 no practical method for use of dsRNA in shrimp farms has been developed to date. The apparent bottleneck for farm-scale applications of RNAi-mediated viral control in shrimp aquaculture is the lack of simple and cost-effective delivery methods. This review summarizes recent studies on use and delivery of dsRNA to shrimp via injection and oral routes in hatcheries and on farms and it discusses the research directions that might lead to development of practical methods for applications with farmed shrimp. Oral delivery methods tested so far include use of dsRNA-expressing bacteria as a component of dry feed pellets or use of living brine shrimp (Artemia) pre-fed with dsRNA before they are fed to shrimp. Also tested have been dsRNA enclosed in nanocontainers including chitosan, liposomes and viral-like particles (VLP) before direct injection or use as components of feed pellets for hatchery or pond-reared shrimp.